Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Ryan Nelson
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.
Purell Battling Class Actions Over Disease Claims While World Scrambles To Increase Hand Sanitizer Supplies
Leading chemical firms, beauty and consumer health companies, even distilleries and medical marijuana cultivators are adapting operations to meet global demand for hand sanitizers amid the COVID-19 pandemic. Meanwhile, plaintiff’s attorneys are busy with multiple class actions against Purell manufacturer GOJO Industries for alleged false advertising following a January warning letter to the firm from the US FDA.
The European Chemicals Agency is working to develop a centralized, expedited authorization process to increase the availability of disinfectants to consumers and healthcare professionals fighting the novel coronavirus. Meanwhile, the ECHA encourages companies to work with national authorities on single-market applications for derogations under the Biocidal Products Regulation to speed up production.
Companies choosing between CBD options – namely broad- or full-spectrum hemp extracts or CBD isolate – need to appreciate the differences and potential legal implications, attorneys say.
California’s Safer Consumer Products regime has been criticized for being too slow to address perceived dangerous chemicals and too reliant on manufacturer-led alternatives analyses. Washington state’s Safer Products program established in 2019 is designed to eliminate those alleged impediments.
The Evergreen State’s California-esque Safer Products for Washington program is looking at phthalates use in the beauty and personal-care sectors as one of its first proposed priority product selections, which could lead to reporting requirements or sales restrictions.